FDA — authorised 22 August 2008
- Marketing authorisation holder: AMGEN
- Status: approved
🇺🇸 Nplate in United States
FDA authorised Nplate on 22 August 2008
Marketing authorisations
FDA — authorised 22 August 2008
- Application: BLA125268
- Marketing authorisation holder: AMGEN
- Local brand name: NPLATE
- Indication: INJECTABLE — SUBCUTANEOUS
- Status: approved
Nplate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Nplate approved in United States?
Yes. FDA authorised it on 22 August 2008; FDA authorised it on 22 August 2008.
Who is the marketing authorisation holder for Nplate in United States?
AMGEN holds the US marketing authorisation.